GUPTA, Vinod Kumar. Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye. Journal of Neuroscience and Neurological Disorders, [S. l.], v. 7, n. 2, p. 134–154, 2023. DOI: 10.29328/journal.jnnd.1001087. Disponível em: https://www.neuroscijournal.com/jnnd/article/view/jnnd-aid1087. Acesso em: 10 oct. 2025.